Current treatment options for pancreatic carcinoma
- PMID: 21491194
- DOI: 10.1007/s11912-011-0164-1
Current treatment options for pancreatic carcinoma
Abstract
Pancreas cancer is a significant cause of cancer mortality; therefore, the development of early diagnostic strategies and effective treatment is essential. Improvements in imaging technology, as well as use of biomarkers such as CA 19-9, are changing the way that pancreas cancer is diagnosed and staged. Although progress in treatment for pancreas cancer has been incremental, development of combination therapies involving both chemotherapeutic and biologic agents is ongoing. This article reviews current strategies in the diagnosis and treatment of resectable and advanced pancreas cancer.
Similar articles
-
Current and future therapies for advanced pancreatic cancer.J Surg Oncol. 2017 Jul;116(1):25-34. doi: 10.1002/jso.24623. Epub 2017 Jun 7. J Surg Oncol. 2017. PMID: 28591939 Review.
-
Borderline resectable pancreatic cancer: on the edge of survival.Cancer Control. 2008 Oct;15(4):295-307. doi: 10.1177/107327480801500404. Cancer Control. 2008. PMID: 18813197 Review.
-
Metastasized pancreatic carcinoma with neoadjuvant FOLFIRINOX therapy and R0 resection.World J Gastroenterol. 2015 May 28;21(20):6384-90. doi: 10.3748/wjg.v21.i20.6384. World J Gastroenterol. 2015. PMID: 26034375 Free PMC article.
-
Locoregional/systemic chemotherapy of locally advanced/metastasized pancreatic cancer with a combination of mitomycin-C and gemcitabine and simultaneous follow-up by imaging methods and tumor markers.Anticancer Res. 1999 Jul-Aug;19(4A):2459-69. Anticancer Res. 1999. PMID: 10470175 Clinical Trial.
-
The evolution of adjuvant and neoadjuvant chemotherapy and radiation for advanced pancreatic cancer: from 5-fluorouracil to GTX.Surg Oncol Clin N Am. 2004 Oct;13(4):711-35, x. doi: 10.1016/j.soc.2004.06.005. Surg Oncol Clin N Am. 2004. PMID: 15350944 Review.
Cited by
-
Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma.Cell Res. 2019 Sep;29(9):725-738. doi: 10.1038/s41422-019-0195-y. Epub 2019 Jul 4. Cell Res. 2019. PMID: 31273297 Free PMC article.
-
An arginine-rich cell penetrating peptide contained anti-gelatinase scFv-LDM fusion protein shows potent antitumor efficacy in pancreatic cancer.J Cancer. 2018 Jan 8;9(4):674-682. doi: 10.7150/jca.22277. eCollection 2018. J Cancer. 2018. PMID: 29556325 Free PMC article.
-
Pancreatic cancer biology and genetics from an evolutionary perspective.Nat Rev Cancer. 2016 Sep;16(9):553-65. doi: 10.1038/nrc.2016.66. Epub 2016 Jul 22. Nat Rev Cancer. 2016. PMID: 27444064 Free PMC article. Review.
-
Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis.Mol Cancer. 2019 Jan 21;18(1):14. doi: 10.1186/s12943-018-0927-5. Mol Cancer. 2019. PMID: 30665410 Free PMC article. Review.
-
Chemotherapy and radiotherapy for advanced pancreatic cancer.Cochrane Database Syst Rev. 2018 Mar 20;3(3):CD011044. doi: 10.1002/14651858.CD011044.pub2. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2024 Dec 5;12:CD011044. doi: 10.1002/14651858.CD011044.pub3. PMID: 29557103 Free PMC article. Updated.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous